Loading company…
Paratek Pharmaceuticals and Radius Health combined to form a specialty pharmaceutical company.
Paratek Pharmaceuticals, Inc. and Radius Health, Inc. combined in March 2026 to form a privately held specialty pharmaceutical company backed by B FLEXION Life Sciences. The combined portfolio includes NUZYRA® for serious community-acquired infections, XHANCE® for chronic rhinosinusitis, and TYMLOS® for osteoporosis. Both companies were portfolio companies of Gurnet Point Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Paratek Pharmaceuticals, Inc. / Radius Health, Inc.? This is my company